Target intelligence / Profile preview

RNA, U6 small nuclear 1123, pseudogene (RNU6-1123P)

Target
RNU6-1123P
Molecular classification
Pseudogene, Non-coding RNA (processed pseudogene of small nuclear RNA), Other
01

Overview

RNA, U6 small nuclear 1123, pseudogene (RNU6-1123P) is a genomic copy of the U6 small nuclear RNA gene, classified as a processed pseudogene. Unlike functional U6 snRNA, which is central to the spliceosome and pre-mRNA splicing in eukaryotes[1][3], RNU6-1123P does not contribute to cellular activity and encodes no proteins. Such pseudogenes are generated by retrotransposition mechanisms, where RNA copies are integrated into the genome but rendered non-functional due to sequence changes or lack of regulatory elements[2][3]. Numerous snRNA pseudogenes are present throughout vertebrate genomes, reflecting retrotransposon activity[2][3]. They play no direct role in cell biology or disease, and have neither clinical nor therapeutic utility. Summary of Key Points: - RNU6-1123P is a non-functional pseudogene, not a receptor or molecular target. - There is nothing to suggest drug relevance, mechanism of action, or biomarker activity. - Its only role is passive: a genomic marker of past retrotransposition events[2]. - It is not considered for therapeutic intervention, nor is it associated with safety concerns[5].

Other names
RNU6-1123PRNA, U6 small nuclear 1123, pseudogene
02

Mechanism of action

None

03

Biological functions

None
04

Disease associations

None known
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 1123, pseudogene (RNU6-1123P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1123, pseudogene (RNU6-1123P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call